Hideki Garren
Chief Tech/Sci/R&D Officer bei PROTHENA CORPORATION PLC
Vermögen: 19 840 $ am 31.03.2024
Profil
Hideki Garren was the founder of Bayhill Therapeutics, Inc. (founded in 2001) where he held the title of Chief Operating & Scientific Officer, Executive VP from 2001 to 2013.
He is currently working as an Independent Director at Coya Therapeutics, Inc. (since 2021) and as the Chief Medical Officer at Prothena Corp.
Plc (since 2021).
In his former positions, he worked as an Executive Director-Translational Medicine Expert at Novartis Pharma AG from 2011 to 2013, and as the Vice President & Global Head-Neuroimmunology at Genentech, Inc. and F.
Hoffmann-La Roche Ltd.
from 2013 to 2021.
He was also a Member at Stanford University.
Dr. Garren holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the California Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
COYA THERAPEUTICS, INC.
0,01% | 22.03.2024 | 2 000 ( 0,01% ) | 19 840 $ | 31.03.2024 |
PROTHENA CORP. PLC
-.--% | 04.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Hideki Garren
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTHENA CORPORATION PLC | Chief Tech/Sci/R&D Officer | 05.04.2021 |
| COYA THERAPEUTICS, INC. | Director/Board Member | 01.06.2021 |
Ehemalige bekannte Positionen von Hideki Garren
| Unternehmen | Position | Ende |
|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.01.2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2021 |
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Founder | 26.12.2013 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.01.2013 |
| Stanford University | Corporate Officer/Principal | - |
Ausbildung von Hideki Garren
| University of California, Los Angeles | Doctorate Degree |
| California Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| COYA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
